Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 2, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Brian Abrahams Maintained (BIIB) at Buy with Increased Target to $292 on, Aug 2nd, 2024
Brian Abrahams of RBC Capital, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $282 to $292 on, Aug 2nd, 2024.
Brian has made no other calls on BIIB in the last 4 months.
There are 10 other peers that have a rating on BIIB. Out of the 10 peers that are also analyzing BIIB, 3 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $214 on, Wednesday, April 17th, 2024
- Geoff Meacham of "B of A Securities" Maintained at Hold with Decreased Target to $260 on, Friday, April 12th, 2024
- Chris Schott of "JP Morgan" Maintained at Hold with Decreased Target to $240 on, Thursday, April 11th, 2024
These are the ratings of the 7 analyists that currently disagree with Brian
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $288 on, Thursday, August 1st, 2024
- Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $294 on, Monday, July 29th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $313 on, Friday, July 12th, 2024
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, May 23rd, 2024
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy and Held Target at $340 on, Thursday, May 16th, 2024
- Morten Herholdt of "HSBC" Maintained at Strong Buy with Increased Target to $342 on, Friday, May 3rd, 2024
- Jay Olson of "Oppenheimer" Maintained at Buy and Held Target at $270 on, Monday, April 29th, 2024
